Funding news
Amani Therapeutics logo

Amani Therapeutics Raises $25.

Recently funded · $25.0M Series aHospitals and Health CareView source

Get the full Amani Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Amani Therapeutics, a biotech company dedicated to developing effective treatments for serious psychiatric illness, has secured $25.0M in a Series A funding round. The investment is poised to accelerate its mission of removing barriers with innovative science, aiming to deliver therapies that restore hope and stability for people living with these conditions.

The company's work focuses on enabling fuller lives for patients by addressing critical unmet needs in psychiatric care. This fresh capital will be instrumental in advancing its innovative scientific approach towards achieving these goals.

From the source

VC · Mar 23, 2026

Amani Therapeutics Raises $25M Series A to Advance Schizophrenia Treatment Candidate AM-01  https://lnkd.in/g8FD6Cxk #funding #vc

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Omni logo

Omni

United States

$14.6M
2
myota logo

myota

United Kingdom

$4.5M
3
Integral Privacy Technologies logo

Integral Privacy Technologies

United States

$18.0M
4
Fusion Bionic GmbH logo

Fusion Bionic GmbH

Germany

$6.3M
5
BitRouterAI logo

BitRouterAI

$65.0M